tiprankstipranks
Trending News
More News >
Akari Therapeutics (AKTX)
NASDAQ:AKTX
US Market
Advertisement

Akari Therapeutics (AKTX) Drug Pipeline

Compare
309 Followers
Drug Name
Condition
Stage
Status
Study Name
Trial Start Date
Article
Nomacopan (Rva576)
Bullous Pemphigoid
Phase III
Withdrawn
Nomacopan Therapy in Adult Patients With Bullous Pemphigoid Receiving Adjunct Oral Corticosteroid Therapy (ARREST-BP)
Sep 15, 2021
Nomacopan (Rva576)
Thrombotic Microangiopathies
Phase III
Terminated
Nomacopan (rVA576) in Transplant Associated Thrombotic Microangiopathy
Nov 19, 2020
Rva576
Bullous Pemphigoid (Bp)
Phase II
Completed
rVA576 in Adult Mild to Moderate Bullous Pemphigoid Subjects
Apr 12, 2019
Rva576
Conjunctivitis, Allergic, Keratoconjunctivitis, Atopic, Keratoconjunctivitis, Vernal
Phase I/II
Terminated
Topical rVA576 for Treatment of Atopic Keratoconjunctivitis
Feb 13, 2019
Rva576
Paroxysmal Nocturnal Hemoglobinuria
Phase III
Terminated
rVA576 (Coversin) Long Term Safety and Efficacy Surveillance Study
Dec 20, 2018
Standard Of Care (Soc), Rva576
Paroxysmal Nocturnal Hemoglobinuria (Pnh)
Phase III
Completed
Treating Paroxysmal Nocturnal Haemoglobinuria Patients With rVA576
Jun 01, 2018
Coversin
Paroxysmal Nocturnal Hemoglobinuria (Pnh)
Phase II
Completed
Coversin in PNH in Patients With Resistance to Eculizumab Due to Complement C5 Polymorphisms
Jan 24, 2018

FAQ

What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
    What is a clinical trial?
    A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
      What drugs does Akari Therapeutics (AKTX) have in its pipeline
      AKTX is currently developing the following drugs: Nomacopan (Rva576), Nomacopan (Rva576), Rva576. These drug candidates are in various stages of clinical development as the company works toward FDA approval.
        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis